as 09-29-2025 3:31pm EST
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Founded: | 2015 | Country: | United States |
Employees: | N/A | City: | WATERTOWN |
Market Cap: | 175.1M | IPO Year: | 2020 |
Target Price: | $8.50 | AVG Volume (30 days): | 1.8M |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.58 | EPS Growth: | N/A |
52 Week Low/High: | $1.08 - $7.14 | Next Earning Date: | 10-30-2025 |
Revenue: | $34,240,000 | Revenue Growth: | 16.55% |
Revenue Growth (this year): | -26.97% | Revenue Growth (next year): | -20.38% |
CCCC Breaking Stock News: Dive into CCCC Ticker-Specific Updates for Smart Investing
Simply Wall St.
19 days ago
Zacks
5 months ago
GlobeNewswire
5 months ago
Simply Wall St.
5 months ago
Zacks
7 months ago
MT Newswires
7 months ago
Simply Wall St.
7 months ago
Zacks
7 months ago
The information presented on this page, "CCCC C4 Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.